These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 8622391)

  • 1. Randomised, double-blind, placebo-controlled study of fluoxetine in chronic fatigue syndrome.
    Vercoulen JH; Swanink CM; Zitman FG; Vreden SG; Hoofs MP; Fennis JF; Galama JM; van der Meer JW; Bleijenberg G
    Lancet; 1996 Mar; 347(9005):858-61. PubMed ID: 8622391
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised, double-blind, placebo-controlled treatment trial of fluoxetine and graded exercise for chronic fatigue syndrome.
    Wearden AJ; Morriss RK; Mullis R; Strickland PL; Pearson DJ; Appleby L; Campbell IT; Morris JA
    Br J Psychiatry; 1998 Jun; 172():485-90. PubMed ID: 9828987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoxetine versus placebo in depressed alcoholic cocaine abusers.
    Cornelius JR; Salloum IM; Thase ME; Haskett RF; Daley DC; Jones-Barlock A; Upsher C; Perel JM
    Psychopharmacol Bull; 1998; 34(1):117-21. PubMed ID: 9564208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoxetine versus placebo for the marijuana use of depressed alcoholics.
    Cornelius JR; Salloum IM; Haskett RF; Ehler JG; Jarrett PJ; Thase ME; Perel JM
    Addict Behav; 1999; 24(1):111-4. PubMed ID: 10189977
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Open-label study of s-citalopram therapy of chronic fatigue syndrome and co-morbid major depressive disorder.
    Amsterdam JD; Shults J; Rutherford N
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):100-6. PubMed ID: 17804135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the effects of mirtazapine and fluoxetine in severely depressed patients.
    Versiani M; Moreno R; Ramakers-van Moorsel CJ; Schutte AJ;
    CNS Drugs; 2005; 19(2):137-46. PubMed ID: 15697327
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of fluoxetine and doxepin in treatment of melancholia in depressed patients.
    Sandor P; Baker B; Irvine J; Dorian P; McKessok D; Mendlowitz S
    Depress Anxiety; 1998; 7(2):69-72. PubMed ID: 9614594
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychophysical distress and alexithymic traits in chronic fatigue syndrome with and without comorbid depression.
    Sepede G; Racciatti D; Gorgoretti V; Nacci M; Pizzigallo E; Onofrj M; Di Giannantonio M; Niolu C; Salerno RM; Gambi F
    Int J Immunopathol Pharmacol; 2011; 24(4):1017-25. PubMed ID: 22230407
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early fluoxetine treatment of post-stroke depression--a three-month double-blind placebo-controlled study with an open-label long-term follow up.
    Fruehwald S; Gatterbauer E; Rehak P; Baumhackl U
    J Neurol; 2003 Mar; 250(3):347-51. PubMed ID: 12638027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Commentary on: randomised, double-blind, placebo-controlled trial of fluoxetine and graded exercise for chronic fatigue syndrome.
    Deale A; Chalder T; Wessely S
    Br J Psychiatry; 1998 Jun; 172():491-2. PubMed ID: 9828988
    [No Abstract]   [Full Text] [Related]  

  • 11. Physical activity in chronic fatigue syndrome: assessment and its role in fatigue.
    Vercoulen JH; Bazelmans E; Swanink CM; Fennis JF; Galama JM; Jongen PJ; Hommes O; Van der Meer JW; Bleijenberg G
    J Psychiatr Res; 1997; 31(6):661-73. PubMed ID: 9447571
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
    Nemeroff CB; Thase ME;
    J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytokine inhibition in chronic fatigue syndrome patients: study protocol for a randomized controlled trial.
    Roerink ME; Knoop H; Bredie SJ; Heijnen M; Joosten LA; Netea MG; Dinarello CA; van der Meer JW
    Trials; 2015 Oct; 16():439. PubMed ID: 26438161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns and predictors of remission, response and recovery in major depression treated with fluoxetine or nortriptyline.
    Joyce PR; Mulder RT; Luty SE; Sullivan PF; McKenzie JM; Abbott RM; Stevens IF
    Aust N Z J Psychiatry; 2002 Jun; 36(3):384-91. PubMed ID: 12060188
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is metabolic dysregulation associated with antidepressant response in depressed women in climacteric treated with individualized homeopathic medicines or fluoxetine? The HOMDEP-MENOP Study.
    Macías-Cortés ED; Llanes-González L; Aguilar-Faisal L; Asbun-Bojalil J
    Homeopathy; 2017 Feb; 106(1):3-10. PubMed ID: 28325221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Double-blind fluoxetine in depressed alcoholic smokers.
    Cornelius JR; Salloum IM; Ehler JG; Jarrett PJ; Cornelius MD; Black A; Perel JM; Thase ME
    Psychopharmacol Bull; 1997; 33(1):165-70. PubMed ID: 9133770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of physical illness on quality of life and antidepressant response in geriatric major depression. Fluoxetine Collaborative Study Group.
    Small GW; Birkett M; Meyers BS; Koran LM; Bystritsky A; Nemeroff CB
    J Am Geriatr Soc; 1996 Oct; 44(10):1220-5. PubMed ID: 8856002
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2016 Dec; 12(12):CD003200. PubMed ID: 27995604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exercise therapy for chronic fatigue syndrome.
    Larun L; Brurberg KG; Odgaard-Jensen J; Price JR
    Cochrane Database Syst Rev; 2015 Feb; (2):CD003200. PubMed ID: 25674924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.